‘Bipolar androgen therapy’ helps patients with tumours that are resistant to conventional hormone treatments.
Highlights
C&EN: Cheaper cryo-EM on the horizon
20 November 2020Thermo Fisher hopes $1 million microscope could broaden access to microscopy method used to determine protein structures.
C&EN: Oxidant may offer a boost to greener rockets
18 November 2020An alternative to polluting ammonium perchlorate shows promise as a propellant ingredient.
C&EN: How one university built a COVID-19 screening system
02 November 2020Campus testing at the University of Illinois at Urbana-Champaign holds important lessons about the strengths and limitations of routine testing regimen.
C&EN: Click chemistry sees first use in humans
22 October 2020Targeting mechanism could help to avoid side effects of powerful anticancer drug.
C&EN: Database brings clarity to chemical weapons lists
08 October 2020Molecular structures and other identifiers will help to compare and contrast chemical warfare agents controlled by three different international frameworks.
TESTIMONIALS
“As an editor and reporter, Mark Peplow is fast, accurate, and versatile. He covers science policy and pure research with equal passion, and his writing combines a scientist’s precision with a journalist’s verve.” Tim Appenzeller
Former Chief Magazine Editor at Nature, now News Editor at Science
"Mark guided me through some of the most challenging stories I've written. These are pieces I might not have attempted were it not for his steady editorial hand." Linda Nordling
Freelance Journalist, South Africa
“Working with Mark is never anything other than a pleasure. He is the kind of editor that writers hope for: able to identify what needs fixing and what doesn’t, bringing to bear a wealth of knowledge, always clear, prompt and easy to talk with. Much of that comes from being a splendid writer himself.”
Philip Ball
Freelance Science Writer
